Changes in procalcitonin in septic shock patients treated with endotoxin adsorption therapy

Similar Items

• Clinical evaluation of endotoxin hemoadsorption therapy (PMX-DHP) for hypercytokinemia caused by septic multiple organ failure
  od: Ikeda, T, i dr.
  Izdano: (2004)
• The role of plasminogen activator inhibitor 1 measurement with endotoxin adsorption therapy (PMX-DHP) for postoperative septic shock patients
  od: Ikeda, T, i dr.
  Izdano: (2007)
• Endotoxin adsorption method may affect serum procalcitonin
  od: Ikeda, T, i dr.
  Izdano: (2008)
• Serum procalcitonin level correlates with endotoxin activity in patients with septic shock
  od: Adamik, B, i dr.
  Izdano: (2015)
• Use of extracorporeal endotoxin elimination therapy for septic shock
  od: Adamik, BA, i dr.
  Izdano: (2013)